What type of study is this?

This is a Experimental Study study.

September 12, 2025Chemical Communications

Carbonic anhydrase-IX targeted copper doped carbon dots as a theranostic probe for treating triple negative breast cancer

View Full Paper

Ask AI

Bookmark

CuCD-Az effectively diagnosed and treated triple negative breast cancer cells, indicating its potential as a theranostic probe.
The study reports a ~3-fold increase in efficiency compared to traditional methods in targeting TNBC cells.
Targeting carbonic anhydrase-IX enhances selectivity and efficacy in cancer therapy, making it a promising strategy.
This method combines diagnosis and treatment, which could streamline therapeutic approaches for patients with TNBC.

Implication

This study demonstrates improved diagnosis and chemodynamic therapy in triple negative breast cancer, suggesting a novel theranostic approach.

Abstract

Herein, we demonstrate selective diagnosis and chemodynamic therapy in triple negative breast cancer (TNBC) cells by carbonic anhydrase-IX targeted acetazolamide functionalized copper doped carbon dots (CuCD-Az). CuCD-Az showed ~3-fold higher...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Khan et al. (2025) studied this question.

synapsesocial.com/papers/68d44b3831b076d99fa54a9f https://doi.org/10.1039/d5cc04653j

View Full Paper

Ask AI

Bookmark

Implication

This study demonstrates improved diagnosis and chemodynamic therapy in triple negative breast cancer, suggesting a novel theranostic approach.

Carbonic anhydrase-IX targeted copper doped carbon dots as a theranostic probe for treating triple negative breast cancer

Key Points

Implication

Abstract

Discussion

Cite This Study

Carbonic anhydrase-IX targeted copper doped carbon dots as a theranostic probe for treating triple negative breast cancer

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading